VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017

Jun 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-06-01

Reporting Person: Kearney Terrence C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-01	Common Stock	A	2188	$0.00	Acquired	6629	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-01	Stock Option (Right to Buy)	$125.71	M	5295	Acquired	2027-05-31	Common Stock (5295)	Direct

Footnotes

F1: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

F2: Fully vested.